Ligand Pharmaceuticals Incorporated Capital Reinvestment Ratio

Latest as of June 2026: 0.00x

Ligand Pharmaceuticals Incorporated capital reinvestment ratio. Ligand Pharmaceuticals Incorporated (LGND) has a Capital Reinvestment Ratio of 0.00x as of June 2026, meaning it reinvests 0% of its operating cash flow ($24.02 Million) in capital expenditures ($26.00K). See Ligand Pharmaceuticals Incorporated free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.

Capital Reinvestment Ratio

0.00x
Capex / Operating Cash Flow

Operating Cash Flow

$24.02 Million
USD

Capital Expenditures

$26.00K
USD

Data as of

Jun 2026
Most recent filing

Capital Reinvestment Ratio of Ligand Pharmaceuticals Incorporated (2003–2025)

Capital reinvestment ratio of Ligand Pharmaceuticals Incorporated from 2003 to 2025. This chart tracks Ligand Pharmaceuticals Incorporated's Capital Reinvestment Ratio across 16 annual periods. See Ligand Pharmaceuticals Incorporated (LGND) financial flexibility to measure the company's free cash flow as a share of total liabilities.

Ligand Pharmaceuticals Incorporated Capital Reinvestment Ratio by Year (2003–2025)

Ligand Pharmaceuticals Incorporated capital reinvestment ratio by year from 2003 to 2025. For the full cash flow conversion analysis, see LGND cash flow metrics.

Year Reinvestment Ratio Operating CF (USD) Capital Expenditures YoY Change
2025 0.01x $49.36 Million $452.00K ▼ -95.5%
2024 0.20x $97.05 Million $19.64 Million ▼ -81.4%
2023 1.09x $49.58 Million $53.85 Million ▲ +735.4%
2022 0.13x $137.85 Million $17.92 Million ▲ +16.9%
2021 0.11x $78.80 Million $8.76 Million ▲ +36.1%
2020 0.08x $54.59 Million $4.46 Million ▲ +33.3%
2018 0.06x $194.06 Million $11.89 Million ▼ -19.9%
2017 0.08x $93.57 Million $7.15 Million ▼ -83.0%
2016 0.45x $63.00 Million $28.32 Million ▲ +72.7%
2015 0.26x $41.73 Million $10.86 Million ▲ +19.0%
2014 0.22x $20.57 Million $4.50 Million ▼ -8.3%
2013 0.24x $20.69 Million $4.94 Million ▼ -99.6%
2012 53.69x $161.00K $8.64 Million ▲ +1161.7%
2005 4.26x $8.37 Million $35.60 Million ▲ +579.4%
2004 0.63x $5.75 Million $3.60 Million ▼ -93.8%
2003 10.16x $274.00K $2.78 Million —
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow